- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Riptide rebrands itself to reflect focus on future
Riptide rebrands itself to reflect focus on futureRiptide Technologies is changing its name to Avreo, a variant of the Greek “avrio” meaning “tomorrow.” The New Orleans-based firm made this move to emphasize its concentration
Riptide rebrands itself to reflect focus on future
Riptide Technologies is changing its name to Avreo, a variant of the Greek avrio meaning tomorrow. The New Orleans-based firm made this move to emphasize its concentration on developing data-management solutions based on emerging technologies. Avreo launched version 1.0 of its XML-based system ARIIS (advanced radiology image and information system) in October (HNN 9/20/00) and is currently gearing up for the RSNA meeting in November.
- Search Again
- Return To HNN Homepage
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
